BioSpace News Archive

Drug Development

New Cell Therapy Player Makes Public Debut at JPM

Affini-T Therapeutics unveiled its mission to target oncogenic driver mutations to deliver transformative therapies intended to cure patients.

January 14, 2022
·
2 min read
·
Alex Keown
Drug Development

UCLA “Kick and Kill” Approach Shows Early Promise in Treating HIV

Researchers from UCLA believe they may have a possible new approach to treating, and potentially eradicating HIV.

January 14, 2022
·
2 min read
·
Alex Keown
Careium AB Signs an Agreement with a Municipality in Skåne Regarding the Medication Robot Dosell

iZafe Group hereby announces that the partner Careium AB has signed an agreement with a municipality in Skåne, which has chosen to introduce the Swedish made medication robot Dosell in its operations.

January 14, 2022
·
1 min read
Oblique Therapeutics is pleased to announce that the United States Patent and Trademark Office has granted a patent for its innovative AbiProt® technology

Oblique Therapeutics AB today announces that key aspects of its AbiProt® technology for discovering and developing pharmacologically tailored antibodies against clinically important targets has been granted by the USPTO as US Patent No. 11,161,901 B2.

January 14, 2022
·
3 min read
Bio NC

Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference

Novan, Inc., announced that data from the Company’s completed Phase 2 and Phase 3 clinical studies of berdazimer 10.3% gel for molluscum contagiosum will be presented at the 2022 Winter Clinical Dermatology Conference, being held January 14-19, 2022, in Koloa, Hawaii.

January 14, 2022
·
5 min read
Policy

APLT INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages Applied Therapeutics, Inc. (APLT) Investors to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Hagens Berman urges Applied Therapeutics, Inc. (NASDAQ: APLT) investors with significant losses to submit your losses now.

January 14, 2022
·
2 min read
2022 will see pharma target nutraceutical products to tap into consumer spending on preventative health

2025 forecast: massive growth expected in consumer-friendly dosages using natural ingredients for proactive & pre-emptive health.

January 14, 2022
·
5 min read
Mobile C-Arms Market Size to Reach USD 1.69 Billion in 2028 Growing at a CAGR of 5.2%, According to Emergen Research

According to Emergen Research, the global mobile C-arms market size was USD 1.12 billion in 2020 and is expected to reach USD 1.69 billion in 2028 and register a revenue CAGR of 5.2% during the forecast period, 2021-2028.

January 14, 2022
·
7 min read
Surgical Instrument Tracking Systems Market Size to Reach USD 488.57 Million in 2028 Growing at a CAGR of 13.2%, According to Emergen Research

According to Emergen Research, the global surgical instrument tracking systems market size was USD 180.44 million in 2020 and is expected to reach USD 488.57 million in 2028 and register a revenue CAGR of 13.2% during the forecast period, 2021-2028.

January 14, 2022
·
7 min read
Drug Discovery Informatics Market To Reach USD 4.09 Billion By 2027, Says Reports And Data

Rising prevalence of chronic diseases and increasing investment in research & development are key factors driving growth of the drug discovery informatics market.

January 14, 2022
·
7 min read